Kei Kishimoto

Kei Kishimoto

Company: Selecta Biosciences Inc.

Job title: Chief Scientific Officer


Strategizing Methods to Mitigate Against Neutralizing Antibodies in AAV Gene Therapy 2:30 pm

• Leveraging bacterial enzymes to circumvent neutralizing antibodies • Exploring novel approaches to dosing patients with pre-existing immunity • Optimizing neutralizing antibody assays to improve standardizationRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.